A recent study reveals that patient-reported care experience declined significantly at hospitals acquired by private equity firms, highlighting the potential impact of private equity acquisitions on patient care.
Baloxavir probably reduced risk of hospital admission for high-risk patients and may reduce time to alleviation of symptoms, without increasing adverse events related to treatment in patients with nonsevere influenza," finds comprehensive network meta-analysis of 73 trials involving 34,332 participants.
New members, Alicia Fernandez, MD, and Ericka Gibson, MD, MPH, bring expertise in health equity and maternal health care to the U.S. Preventive Services Task Force, contributing to evidence-based recommendations about clinical preventive services such as screenings, and counseling services.
FDA grants first-ever marketing authorization for ZYN nicotine pouches following a scientific review that showed lower health risks compared to traditional tobacco products and minimal youth usage.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
New research challenges conventional wisdom as never-smokers with NSCLC present with more advanced disease but achieve median survival of 6.6 years versus 3.9 years in smokers, upending traditional prognostic assumptions.
Keros Therapeutics halts testing of experimental blood pressure treatment due to safety concerns during mid-stage trial, citing excess fluid build up around the heart in patients with pulmonary arterial hypertension.